Table 4. Characteristics of patients with CR versus no CR.
| Characteristics | CR | No CR | P |
|---|---|---|---|
| No. of patients | 27 | 16 | |
| Female sex, N (%) | 15 (55.6) | 6 (37.5) | 0.256 |
| Median age, y (range) | 54 (20-65) | 57.5 (35-65) | 0.061 |
| AHD, N (%) | 3 (11.11) | 7 (43.75) | 0.021 |
| Median WBC count, ×109/L (range) | 1.6 (0.3-51.6) | 3.2 (1.2-13.3) | 0.472 |
| Median HGB level, g/L (range) | 89 (40-151) | 76.5 (48-109) | 0.211 |
| Median platelet count, ×109/L (range) | 53 (9-212) | 50.5 (6-248) | 0.323 |
| Cytogenetics, N (%) poor intermediate favorable |
7 (25.9) 15 (55.6) 5 (18.5) |
12 (75) 4 (25) 0 |
0.003 |
| Induction treatment, N (%) XA regimen HAG regimen |
14 (51.9) 13 (48.1) |
13 (81.25) 3 (18.75) |
0.062 |
CR, complete remission; AHD, anterior hematological disease; HGB, hemoglobin; XA, anthracyclines and cytarabine; HAG, homoharringtonine, cytarabine and G-CSF;